Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
|Slideshows|June 17, 2015
10 FDA-Approved Drugs for Primary Care
Author(s)Grace Halsey
Since January 2015, the FDA has approved more than a dozen drugs indicated for primary care diseases. Here, a quick slide update on 10 of them.
Advertisement
Since January 2015, the FDA has approved more than a dozen medications indicated for primary care diseases. In the slides above, a brief look at 10 of the newest approvals, starting with the most recent.
Advertisement
Related to this article
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood screening test.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
EASD 2026: Oral semaglutide users lost 4.1% of body weight 3 months after switching from injections in an observational study without a comparator group.
Real-world phase 4 data show fezolinetant eases menopausal hot flashes and improves sleep, cutting nighttime awakenings by 2.6 by week 12.
Advertisement
Advertisement
Trending on Patient Care Online
1
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
2
Updated Freenome CRC Blood Test Detects 18.2% of Advanced Precancerous Lesions
3
Building Clinician Confidence to Prescribe HIV PrEP in Primary Care
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5